Jury Awards $57M To Ravgen In Genetic Test Patent Row
A Texas federal jury found Tuesday afternoon that genetic testing company Natera infringed a patent from rival Ravgen, awarding the Maryland-based biotech firm $57 million in damages, according to both parties....To view the full article, register now.
Already a subscriber? Click here to view full article